JP2023532736A5 - - Google Patents
Info
- Publication number
- JP2023532736A5 JP2023532736A5 JP2022581583A JP2022581583A JP2023532736A5 JP 2023532736 A5 JP2023532736 A5 JP 2023532736A5 JP 2022581583 A JP2022581583 A JP 2022581583A JP 2022581583 A JP2022581583 A JP 2022581583A JP 2023532736 A5 JP2023532736 A5 JP 2023532736A5
- Authority
- JP
- Japan
- Prior art keywords
- disease
- pharmaceutical composition
- composition according
- compound
- therapeutic agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063047440P | 2020-07-02 | 2020-07-02 | |
| US63/047,440 | 2020-07-02 | ||
| PCT/US2021/038408 WO2022005807A1 (en) | 2020-07-02 | 2021-06-22 | Compounds for drug delivery across blood-brain barrier |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023532736A JP2023532736A (ja) | 2023-07-31 |
| JP2023532736A5 true JP2023532736A5 (https=) | 2024-06-27 |
Family
ID=77317394
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022581583A Pending JP2023532736A (ja) | 2020-07-02 | 2021-06-22 | 血液脳関門を通過する薬物送達のための化合物 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20230257420A1 (https=) |
| EP (1) | EP4175715A1 (https=) |
| JP (1) | JP2023532736A (https=) |
| CA (1) | CA3184089A1 (https=) |
| WO (1) | WO2022005807A1 (https=) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003049772A2 (en) * | 2001-12-11 | 2003-06-19 | The Board Of Trustees Of The Leland Stanford Junior University | Guanidinium transport reagents and conjugates |
| US20180156826A1 (en) * | 2015-06-08 | 2018-06-07 | The Board Of Regents Of The University Of Texas Sy Stem | Compositions and methods for diagnosis of autism spectrum disorder |
| WO2017015644A1 (en) * | 2015-07-23 | 2017-01-26 | University Of Houston System | Cancer specific lipid targeted peptidomimetics |
-
2021
- 2021-06-22 CA CA3184089A patent/CA3184089A1/en active Pending
- 2021-06-22 JP JP2022581583A patent/JP2023532736A/ja active Pending
- 2021-06-22 EP EP21754858.5A patent/EP4175715A1/en active Pending
- 2021-06-22 WO PCT/US2021/038408 patent/WO2022005807A1/en not_active Ceased
- 2021-06-22 US US18/011,649 patent/US20230257420A1/en active Pending